Chimeric Antigen Receptor T-Cells and Cardiovascular Toxicity: Cause for Concern?
Patrizio Lancellotti1, Marie Moonen2, Maurizio Galderisi3
1Department of Cardiology, Groupe Interdisciplinaire de Genoproteomique Appliquee Cardiovascular Sciences, University of Liège, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.
Journal of the American College of Cardiology
|December 21, 2019
Abstract
No abstract available in PubMed .
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.2K
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
12.4K
